ATELLICA IM NT‑PROBNP(PBNP) - COFEPRIS Registration 1721R2021 SSA
Access comprehensive regulatory information for ATELLICA IM NT‑PROBNP(PBNP) (ATELLICA IM NT‑PROBNP(PBNP)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1721R2021 SSA and manufactured by ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on October 29, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA IM NT‑PROBNP(PBNP) ESTÁ PREVISTO PARA USODIAGNÓSTICO IN VITRO EN LADETERMINACIÓN CUANTITATIVA DELPROPÉPTIDO NATRIURÉTICO CEREBRAL N-
THE ATELLICA IM NT-PROBNP(PBNP) ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF BRAIN NATRIURETIC PEPTIDE N-